RBCK1 is an endogenous inhibitor for triple negative breast cancer via hippo/YAP axis
Zhongbo Li(Henan Medical University), Ting Zhuang(Xinxiang Medical University)
Cited by 16
Related Papers
SMURF1 facilitates estrogen receptor ɑ signaling in breast cancer cells
|Journal of Experimental & Clinical Cancer Research|2018|69
SHARPIN stabilizes estrogen receptor α and promotes breast cancer cell proliferation
|Oncotarget|2017|35
RNF31 represses cell progression and immune evasion via YAP/PD-L1 suppression in triple negative breast Cancer
|Journal of Experimental & Clinical Cancer Research|2022|22
TRIM3 facilitates estrogen signaling and modulates breast cancer cell progression
|Cell Communication and Signaling|2022|17
TRIM3 Facilitates Estrogen Signaling and Modulates Breast Cancer Cell Progression
|Research Square|2021|0